SARS-CoV2
Showing NaN - NaN of 4
Solid Tumor, Sars-CoV2, Hematological Malignancy Trial in New York (BMS-986253)
Terminated
- Solid Tumor
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 18, 2021
Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)
Completed
- Sars-CoV2
- COVID
- Enoxaparin
- Prophylactic/Intermediate Dose Enoxaparin
-
Newark, New Jersey
- +5 more
Nov 17, 2021
COVID-19, COVID19, Sars-CoV2 Trial in New York (Hydroxychloroquine, Placebo)
Withdrawn
- COVID-19
- +3 more
- Hydroxychloroquine
- Placebo
-
New York, New YorkMemorial Sloan - Kettering Cancer Center
Oct 29, 2020